Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.
Journal: Frontiers in oncology
Published: April 30, 2025
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.
Journal: Cancer research communications
Published: February 23, 2024
Challenging the standard of care in advanced melanoma: focus on pembrolizumab.
Journal: Cancer management and research
Published: October 14, 2017
Showing 1-3 of 3
Last Updated: 09/26/2026